SORRENTO AND LEE’S PHARMACEUTICAL ENTER INTO EXCLUSIVE CHINA LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE ANTI-PD-L1 ANTIBODY 2014.10.06

 
 
  Download  


© Lee's Pharmaceutical Holdings Limited     Terms of Use   |   Privacy Statement Designed by YSD